Great people form the core of any great organization. PreludeDx is always looking for highly qualified people with a passion for improving the lives of cancer patients. We will periodically post information about openings but are always interested in hearing from those who believe in our mission and values.
For more information, contact: careers@preludedx.com
Troy Bremer, PhD, founder and CSO of PreludeDx, and Rachel Rabinovitch, MD, FASTRO, Professor of Radiation Oncology at University of Colorado, discuss DCISionRT and how it is used in the real-world clinical setting and the resulting changes in practice of precision medicine.
Troy Bremer, PhD; Julie Margenthaler, MD, FACS; and Chirag Shah, MD discuss the evaluation and use of DCISionRT in real-world setting, the resulting changes in practice of precision medicine, and the introduction of DCISionRT with novel residual risk subtype.
“In my follow-up appointment with the radiation oncologist, he reviewed the DCISionRT test results and concluded that ‘these test results are based on your biology and there is no need for you to have radiation’. So, I was done with treatment! The doctors will continue to monitor me and if my cancer comes back, we can still consider other options at that time.”
“Choose to be your own advocate. Get as much information as you can. Then with all the information in hand, you can decide with your family, physicians and God what is best for you. For me, the DCISionRT test was critical in helping me make a personalized decision.”
“The most gratifying part of my job is taking care of breast cancer patients. They have a fight in them. They want to get better, so they really listen. My initial conversations with my patients typically take about an hour to explain their particular type of breast cancer and the various treatment options available to them. I caution them that they are going to hear stories from a multitude of people who are going to share their experiences and give ‘advice’. I let them know that their cancer is specific to them, and their situation may be different. My patients deserve a personalized diagnosis and treatment plan.”
